MyBlueDotsAspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics MyBlueDots2 weeks ago01 mins VANCOUVER, British Columbia–(BUSINESS WIRE)– #biotech–Aspect Biosystems secures $115M Series B to advance bioprinted tissue therapeutics, accelerating development of functional cures for serious diseases Post navigation Previous: Resumen: Biocytogen y Acepodia combinan fuerzas para desarrollar anticuerpos biespecíficos y ADC de carga doble para el tratamiento de tumores complejosNext: NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
People who are autistic and transgender/gender diverse have poorer health and health care, study finds MyBlueDots17 hours ago 0
Digital therapeutics: Exploring the road to commercialization across international markets MyBlueDots21 hours ago 0